Clinical utility of newly developed immunoassays for serum concentrations of adalimumab and anti-adalimumab antibodies in patients with Crohn’s disease
Hirotsugu Imaeda(Shiga University of Medical Science), Akira Andoh(Shiga University of Medical Science), Shigeki Bamba(Shiga University of Medical Science), Masaya Sasaki(Shiga University of Medical Science), Kenichiro Takahashi(Seiwa Hospital), Tomoyuki Tsujikawa, Yoshihide Fujiyama(Shiga University of Medical Science), Takehide Fujimoto
Cited by 90
Related Papers
Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice
|Clinical Immunology|2003|491
Interleukin-22, a Member of the IL-10 Subfamily, Induces Inflammatory Responses in Colonic Subepithelial Myofibroblasts
|Gastroenterology|2005|477
Decreased abundance of <i><scp>F</scp>aecalibacterium prausnitzii</i> in the gut microbiota of <scp>C</scp>rohn's disease
|Journal of Gastroenterology and Hepatology|2012|301
Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis
|Journal of Gastroenterology|2010|252
Cross-sectional Imaging in Crohn Disease
|Radiographics|2004|242